Patent: 5,371,193
✉ Email this page to a colleague
Summary for Patent: 5,371,193
Title: | Mammalian cytokine, IL-11 |
Abstract: | A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system. |
Inventor(s): | Bennett; Frances K. (Melrose, MA), Paul; Stephen R. (Boston, MA), Yang; Yu-Chung (Indianapolis, IN) |
Assignee: | Genetics Institute, Inc. - Legal Affairs (Cambridge, MA) |
Application Number: | 08/017,522 |
Patent Claims: | see list of patent claims |
Details for Patent 5,371,193
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Inc. | NEUMEGA | oprelvekin | For Injection | 103694 | November 25, 1997 | ⤷ Sign Up | 2011-12-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,371,193
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9107495 | ⤷ Sign Up |
United States of America | 6066317 | ⤷ Sign Up |
United States of America | 5854028 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |